Search

Start Over Coverage 695-704

2. Epoxyeicosanoids in hypertension

Creator:
Imig , J. D.
Format:
bez média and svazek
Type:
model:article and TEXT
Subject:
epoxyeicosatrienoic acid, natriuresis, endothelium, and sodium channels
Language:
English
Description:
Epoxyeicosatrienoic acids (EETs) are also known as epoxyeicosanoids that have renal and cardiovascular actions. These renal and cardiovascular actions can be regulated by soluble epoxide hydrolase (sEH) that degrades and inactivates EETs. Extensive animal hypertension studies have determined that vascular, epithelial transport, and anti-inflammatory actions of EETs lower blood pressure and decrease renal and cardiovascular disease progression. Human studies have also supported the notion that increasing EET levels in hypertension could be beneficial. Pharmacological and genetic approaches to increase epoxyeicosanoids in several animal models and humans have found improved endothelial vascular function, increased sodium excretion, and decreased inflammation to oppose hypertension and associated renal and cardiovascular complications. These compelling outcomes support the concept that increasing epoxyeicosanoids via sEH inhibitors or EET analogs could be a valuable hypertension treatment.
Rights:
http://creativecommons.org/publicdomain/mark/1.0/ and policy:public